Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

817
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
817
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

48
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.3K
Hormonal Regulation01:33

Hormonal Regulation

33.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.7K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

1.8K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increasing the number of surgically cured primary aldosteronism patients: The promise of simplified diagnosis and advanced nuclear adrenocortical imaging.

American journal of surgery·2023
Same author

Automated Item Generation: impact of item variants on performance and standard setting.

BMC medical education·2023
Same author

Early Dalmatian farmers specialized in sheep husbandry.

Scientific reports·2023
Same author

Novel imaging techniques in refractory pituitary adenomas.

Pituitary·2023
Same author

Secondary amenorrhoea with absent axillary hair.

European journal of internal medicine·2023
Same author

The influence of candidates' physical attributes on patient ratings in simulated assessments of clinical practice.

Medical teacher·2022
Same journal

Hemodynamic Evolution of Heart Failure from Hypertension: Lower Stroke Volume Index and Higher Heart Rate.

American journal of hypertension·2026
Same journal

Opposite Seasonal Variation in Nighttime and Morning Blood Pressure: A Longitudinal Study of Patients with Hypertension.

American journal of hypertension·2026
Same journal

Screening for Postprandial Hypotension: The Importance of Home Blood Pressure Monitoring.

American journal of hypertension·2026
Same journal

Distinct Mediating Roles of Hypertension in Arterial Stiffness Mechanisms Associated with Cardiovascular Disease Risk: A Community-Based Cohort Study.

American journal of hypertension·2026
Same journal

Long-term systolic blood pressure time in target and risk of cardiovascular events in older adults: a secondary analysis of the ASPREE cohort.

American journal of hypertension·2026
Same journal

Estimated Pulse Wave Velocity Predicts Outcomes After Acute Ischemic Stroke: A Multinational Cohort Analysis.

American journal of hypertension·2026
See all related articles

Related Experiment Video

Updated: Sep 9, 2025

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

23.6K

Is It Time to Retire Aldosterone Suppression Testing?

G A Kline1, A A Leung1, D Orton2

  • 1Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

American Journal of Hypertension
|September 1, 2025
PubMed
Summary
This summary is machine-generated.

Primary aldosteronism (PA) diagnosis using aldosterone suppression tests is unreliable due to biochemical spectrum, assay variability, and multifactorial pathophysiology. Current evidence suggests retiring these traditional tests for PA diagnosis.

Keywords:
aldosteroneblood pressurehypertensionprimary aldosteronismsecondary hypertension

More Related Videos

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

8.2K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

3.7K

Related Experiment Videos

Last Updated: Sep 9, 2025

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

23.6K
Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

8.2K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

3.7K

Area of Science:

  • Endocrinology
  • Hypertension Research
  • Diagnostic Medicine

Background:

  • Primary aldosteronism (PA) is the most common cause of endocrine hypertension.
  • Diagnosis traditionally relies on aldosterone suppression tests, assessing the renin-angiotensin-aldosterone pathway.
  • These tests have been standard for decades based on early pathophysiologic studies.

Purpose of the Study:

  • To critically appraise the diagnostic utility of traditional aldosterone suppression testing for PA.
  • To highlight modern evidence challenging the validity and reliability of these tests.
  • To propose a re-evaluation of PA diagnostic strategies.

Main Methods:

  • Review of modern understanding of PA pathophysiology.
  • Critical appraisal of diagnostic test studies, including meta-analyses.
  • Analysis of a recent prospective, blinded study on saline suppression testing.

Main Results:

  • Suppression testing faces challenges: continuous biochemical spectrum, aldosterone assay uncertainty, multifactorial PA pathophysiology, and study biases.
  • A recent study showed saline suppression testing lacked diagnostic discrimination.
  • Meta-analyses indicate overestimation of diagnostic value due to biases and confounders.

Conclusions:

  • Traditional aldosterone suppression testing is scientifically unsuited for PA diagnosis or disease definition.
  • The continuous nature of PA and assay limitations render single diagnostic thresholds invalid.
  • Evidence supports retiring suppression testing and exploring new diagnostic approaches for PA.